[Chronic obstructive lung diseases associated with systemic arterial hypertension].
A total of 203 patients with chronic obstructive pulmonary diseases (COPD) with normal blood pressure (BP) as well as with systemic arterial hypertension of different character (labile and stable pulmonogenic essential hypertension) were examined. It was established that if COPD is associated with labile pulmonogenic hypertension and essential hypertension, the underlying disease runs a more benign course. In patients with COPD associated with normal BP or with labile pulmonogenic hypertension, use can be made of broncholytic drugs of different adrenoreceptor action. In associated COPD and stable pulmonogenic hypertension or essential hypertension it is desirable to administer selective stimulants of beta-2-adrenoreceptors, e.g. salbutamol.
Kubyshkin
V F
VF
Soldatchenko
S S
SS
Konovalov
V I
VI
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage; D000420:Albuterol / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000008:administration & dosage; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D008173:Lung Diseases, Obstructive / Q000150:complications* / Q000188:drug therapy; D009921:Metaproterenol / Q000008:administration & dosage
D000318:Adrenergic beta-Agonists; D000959:Antihypertensive Agents; D009921:Metaproterenol; D000420:Albuterol; D004837:Epinephrine
Osobennosti techeniia khronicheskikh obstruktivnykh zabolevaniĭ legkikh v sochetatii s sistemnoĭ arterial'noĭ gipertenzieĭ.